Abstract
<h3>Background and importance</h3> Secukinumab is an immunoglobulin G1 monoclonal antibody that selectively binds to interleukin 17A and inhibits its interaction with the IL-A receptor. It is indicated in psoriasis (Ps),...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have